Flamifast 50 mg 30 tablets
Hikma Pharmaceuticals
Hikma Pharmaceuticals
Overview
Flamifast 50 mg is a fast-acting oral medicine containing diclofenac potassium, formulated as orally disintegrating tablets for the acute treatment of migraine attacks in adults.
Key Benefits
Flamifast is indicated for the acute treatment of migraine attacks, with or without aura, in adults aged 18 and over. The tablets dissolve quickly in the mouth without the need for water, offering a convenient option when migraine symptoms strike. It is not intended for the prevention of migraine, and its effectiveness for cluster headaches has not been established.
How to Use
Take one 50 mg tablet at the onset of a migraine attack, ideally on an empty stomach with water only, as taking it with food may reduce effectiveness. Use the lowest effective dose for the shortest duration, as directed by your pharmacist or physician.
Active Ingredients
Diclofenac Potassium.
Precautions
Not for long-term or preventive use. Consult a physician before use if pregnant, breastfeeding, or with a history of stomach, kidney, or heart conditions.
Storage
Store in a cool, dry place away from direct sunlight and out of reach of children.